Relmada Therapeutics RLMD
NASDAQ RLMD
$3.73 -0.06 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Revenue (2012 - 2013)

Updated

Relmada Therapeutics' Revenue was $5,129 in FY2013, down 35.4% from $7,941 in FY2012.

Analysis

Relmada Therapeutics (RLMD) Revenue (2012 - 2013) Analysis & Trends

  • Per Business Quant data, Revenue in earlier years was $7,941 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Relmada Therapeutics 404.28 Mn 404.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2013 1,850.00
May 31, 2013 634.00
Feb 28, 2013 2,346.00
Nov 30, 2012 2,149.00
Aug 31, 2012 1,515.00
May 31, 2012 400.00
API Access

Relmada Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RLMD&period=max&api_key=YOUR_API_KEY